An update on pharmacological interventions for diabetic foot ulcers.

Christy L. Scimeca, Manish Bharara, Timothy K. Fisher, Heather Kimbriel, David G Armstrong, David G. Armstrong

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Diabetic foot ulcers are the most common lower extremity complications of diabetes. Peripheral neuropathy and peripheral vascular disease are the underlying risk factors for diabetic foot ulcers, subsequently leading to infections and requiring antimicrobial therapy for the management of the disease. Each risk factor is a target for clinical intervention, with the intent to delay or prevent disease progression to amputation. The effective therapy includes interdisciplinary care, which involves optimized pharmacological interventions in concert with other treatments such as debridement strategies and specialized wound dressings. The pharmacological therapy alone cannot lead to successful therapy, and therefore, these supplementary techniques/modalities should not be overlooked. It is therefore the aim of this report to review various pharmacological interventions, specific to the diabetic foot and wound healing, along with incorporation of advanced therapies required to achieve a multifaceted treatment of diabetic foot ulcers and provide basis for superior drugs as well as drug delivery systems.

Original languageEnglish (US)
Pages (from-to)285-302
Number of pages18
JournalFoot & ankle specialist
Volume3
Issue number5
StatePublished - Oct 2010

Fingerprint

Diabetic Foot
Pharmacology
Therapeutics
Peripheral Vascular Diseases
Peripheral Nervous System Diseases
Debridement
Diabetes Complications
Drug Delivery Systems
Bandages
Disease Management
Amputation
Wound Healing
Disease Progression
Lower Extremity
Wounds and Injuries
Infection
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Scimeca, C. L., Bharara, M., Fisher, T. K., Kimbriel, H., Armstrong, D. G., & Armstrong, D. G. (2010). An update on pharmacological interventions for diabetic foot ulcers. Foot & ankle specialist, 3(5), 285-302.

An update on pharmacological interventions for diabetic foot ulcers. / Scimeca, Christy L.; Bharara, Manish; Fisher, Timothy K.; Kimbriel, Heather; Armstrong, David G; Armstrong, David G.

In: Foot & ankle specialist, Vol. 3, No. 5, 10.2010, p. 285-302.

Research output: Contribution to journalArticle

Scimeca, CL, Bharara, M, Fisher, TK, Kimbriel, H, Armstrong, DG & Armstrong, DG 2010, 'An update on pharmacological interventions for diabetic foot ulcers.', Foot & ankle specialist, vol. 3, no. 5, pp. 285-302.
Scimeca, Christy L. ; Bharara, Manish ; Fisher, Timothy K. ; Kimbriel, Heather ; Armstrong, David G ; Armstrong, David G. / An update on pharmacological interventions for diabetic foot ulcers. In: Foot & ankle specialist. 2010 ; Vol. 3, No. 5. pp. 285-302.
@article{35f326946d3c4844adacb41eae940f78,
title = "An update on pharmacological interventions for diabetic foot ulcers.",
abstract = "Diabetic foot ulcers are the most common lower extremity complications of diabetes. Peripheral neuropathy and peripheral vascular disease are the underlying risk factors for diabetic foot ulcers, subsequently leading to infections and requiring antimicrobial therapy for the management of the disease. Each risk factor is a target for clinical intervention, with the intent to delay or prevent disease progression to amputation. The effective therapy includes interdisciplinary care, which involves optimized pharmacological interventions in concert with other treatments such as debridement strategies and specialized wound dressings. The pharmacological therapy alone cannot lead to successful therapy, and therefore, these supplementary techniques/modalities should not be overlooked. It is therefore the aim of this report to review various pharmacological interventions, specific to the diabetic foot and wound healing, along with incorporation of advanced therapies required to achieve a multifaceted treatment of diabetic foot ulcers and provide basis for superior drugs as well as drug delivery systems.",
author = "Scimeca, {Christy L.} and Manish Bharara and Fisher, {Timothy K.} and Heather Kimbriel and Armstrong, {David G} and Armstrong, {David G.}",
year = "2010",
month = "10",
language = "English (US)",
volume = "3",
pages = "285--302",
journal = "Foot and Ankle Specialist",
issn = "1938-6400",
publisher = "SAGE Publications Ltd",
number = "5",

}

TY - JOUR

T1 - An update on pharmacological interventions for diabetic foot ulcers.

AU - Scimeca, Christy L.

AU - Bharara, Manish

AU - Fisher, Timothy K.

AU - Kimbriel, Heather

AU - Armstrong, David G

AU - Armstrong, David G.

PY - 2010/10

Y1 - 2010/10

N2 - Diabetic foot ulcers are the most common lower extremity complications of diabetes. Peripheral neuropathy and peripheral vascular disease are the underlying risk factors for diabetic foot ulcers, subsequently leading to infections and requiring antimicrobial therapy for the management of the disease. Each risk factor is a target for clinical intervention, with the intent to delay or prevent disease progression to amputation. The effective therapy includes interdisciplinary care, which involves optimized pharmacological interventions in concert with other treatments such as debridement strategies and specialized wound dressings. The pharmacological therapy alone cannot lead to successful therapy, and therefore, these supplementary techniques/modalities should not be overlooked. It is therefore the aim of this report to review various pharmacological interventions, specific to the diabetic foot and wound healing, along with incorporation of advanced therapies required to achieve a multifaceted treatment of diabetic foot ulcers and provide basis for superior drugs as well as drug delivery systems.

AB - Diabetic foot ulcers are the most common lower extremity complications of diabetes. Peripheral neuropathy and peripheral vascular disease are the underlying risk factors for diabetic foot ulcers, subsequently leading to infections and requiring antimicrobial therapy for the management of the disease. Each risk factor is a target for clinical intervention, with the intent to delay or prevent disease progression to amputation. The effective therapy includes interdisciplinary care, which involves optimized pharmacological interventions in concert with other treatments such as debridement strategies and specialized wound dressings. The pharmacological therapy alone cannot lead to successful therapy, and therefore, these supplementary techniques/modalities should not be overlooked. It is therefore the aim of this report to review various pharmacological interventions, specific to the diabetic foot and wound healing, along with incorporation of advanced therapies required to achieve a multifaceted treatment of diabetic foot ulcers and provide basis for superior drugs as well as drug delivery systems.

UR - http://www.scopus.com/inward/record.url?scp=79953009602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953009602&partnerID=8YFLogxK

M3 - Article

C2 - 20685955

AN - SCOPUS:79953009602

VL - 3

SP - 285

EP - 302

JO - Foot and Ankle Specialist

JF - Foot and Ankle Specialist

SN - 1938-6400

IS - 5

ER -